Image Systems halts acquisition of NortechMonitor vendor Image Systems has withdrawn its letter of intent to purchase the Imaging Systems division of Nortech Systems. The Minnetonka, MN-based firm said the two companies could not come to an
Monitor vendor Image Systems has withdrawn its letter of intent to purchase the Imaging Systems division of Nortech Systems. The Minnetonka, MN-based firm said the two companies could not come to an agreement during the due diligence process on how to address the existing Nortech warranty liability on previously shipped products.
Image Systems has been designing and manufacturing high-resolution displays since 1988; currently about 80% of the companys business is in medical imaging. Its OEM customers include GE, Toshiba, and Marconi; other customers include DR Systems, Kodak/Cemax-Icon, and IBM (for DIN-PACS).
Image Systems and Nortech, located in Plymouth, MN, have a long history together. Both originally began as divisions of Cassette Powered Typewriters, which is no longer in business. They became competitors in the last few years when Nortech first entered the medical market.
© 2000 Miller Freeman, Inc., a United News & Media company
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.